Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on
top health stories.
Study: 2 percent of Americans have new hips, knees
10 Mar 2014 at 10:25pm
It's not just grandma with a new hip and your uncle with a new knee. More than 2 of every 100 Americans now have an artificial joint, doctors are reporting.
Stigma hinders efforts to combat leprosy in India
9 Mar 2014 at 11:13am
TAHIRPUR, India (AP) ? At first, Ashok Yadav ignored the patches of pink skin on his arm. But when pale sores erupted on his body and he lost sensation in his fingertips, a doctor issued the devastating diagnosis: Yadav had leprosy.
Doctors hope for cure in a 2nd baby born with HIV
5 Mar 2014 at 3:34pm
A second baby born with the AIDS virus may have had her infection put into remission and possibly cured by very early treatment ? in this instance, four hours after birth.
A year on, Pope Francis faces challenges meeting reform hopes
11 Mar 2014 at 8:01am
By Tom Heneghan, Religion Editor (Reuters) - In the year since his surprise election, Pope Francis has raised so many hopes of imminent changes in Church teaching that managing all those expectations is going to be a challenge. The Argentine-born pontiff has caught world attention by suggesting he might ease the Catholic Church's strict rules on divorce, birth control, married or women priests and gay unions. Off-the-cuff comments such as "who am I to judge?" about gays has contrasted with the more distant style of his predecessors John Paul and Benedict. But while his words and public appearances have struck a chord with many Catholics, anyone hoping for a quick turnaround on those headline-grabbers is likely to be disappointed, said Boston College theologian Richard Gaillardetz.
Wall Street little changed, near record highs
11 Mar 2014 at 7:59am
By Chuck Mikolajczak NEW YORK (Reuters) - U.S. stocks were little changed on Tuesday as investors found few reasons to push the S&P 500 above its recent record high, as tensions in Ukraine continued. Despite setting a record high on March 7, the S&P 500 has been range-bound over the last few sessions, amid a dearth of corporate earnings or data-related incentives to push equities higher. "The market has growing pains here, and rightfully so," said Peter Cardillo, chief market economist at Rockwell Global Capital in New York. "Basically we are at high levels, there are a lot of warnings out there, a lot of signs the market may be topping out." Investors were also wary in light of events in Ukraine.
FDA says Senomyx sweetener enhancer safe; shares jump
11 Mar 2014 at 7:57am
(Reuters) - Senomyx Inc said the U.S. health regulator designated its Sweetmyx food flavoring safe, paving the way for customers such as PepsiCo Inc to add it in drinks to reduce the use of sugar or sugar substitutes. Senomyx shares jumped as much as 24 percent to their highest in nearly seven years after the U.S. Food and Drug Administration determined Sweetmyx to be Generally Recognized As Safe (GRAS) under the Federal Food, Drug and Cosmetic Act. PepsiCo has exclusive rights to use Sweetmyx worldwide in all non-alcoholic beverages. PepsiCo shares were up 1 percent.
The children of Japan's Fukushima battle an invisible enemy
11 Mar 2014 at 7:36am
By Toru Hanai and Elaine Lies KORIYAMA, Japan (Reuters) - Some of the smallest children in Koriyama, a short drive from the crippled Fukushima nuclear plant, barely know what it's like to play outside - fear of radiation has kept them indoors for much of their short lives. Though the strict safety limits for outdoor activity set after multiple meltdowns at the Fukushima Dai-ichi nuclear plant in 2011 have now been eased, parental worries and ingrained habit mean many children still stay inside. And the impact, three years on, is now starting to show, with children experiencing falling strength, lack of coordination - some cannot even ride a bicycle - and emotional issues like shorter tempers, officials and educators say. "There are children who are very fearful.
Descent into madness entwines Van Gogh, Artaud at Paris exhibition
11 Mar 2014 at 7:19am
By Alexandria Sage PARIS (Reuters) - The shrieks of mad women assault visitors entering the Musee d'Orsay's new exhibit on Vincent Van Gogh, an arresting look at the painter's work as seen through the eyes of the late avant-garde French theatre director and playwright Antonin Artaud. "The Man Driven to Suicide by Society", opening on Tuesday in Paris, is a fitting title for a display of 55 Van Gogh works using Artaud's own commentary to see them in a new light. Artaud - one of the great theorizers about the stage, renowned for his short but seminal 1938 tract "The Theatre of Cruelty" - was, like Van Gogh, tormented throughout his life by hallucinations and hospitalized in psychiatric asylums.
Obama takes health plan pitch to edgy comedy show
11 Mar 2014 at 6:34am
By Mark Felsenthal WASHINGTON (Reuters) - President Barack Obama took his quest to sign young people up for health insurance to a comedy website on Tuesday, where he traded insults with host Zach Galifianakis while plugging his signature Obamacare health program. Obama sat for an interview on "Between Two Ferns with Zach Galifianakis," on the Funny or Die comedy website. Obama got the chance to plug his signature health care program, but not until he'd been subjected to questions like "What is it like to be the last black president?" and "What should be done about North Ikea?" The administration is stepping up efforts to increase youth participation in Obamacare, also known as the Affordable Care Act.
Missed ADHD Diagnosis, Lost Childhood
11 Mar 2014 at 6:07am
Andrea Frank is an adult with ADHD. This is her story.
Court denies Myriad motion to block rival genetic tests
11 Mar 2014 at 6:01am
(Reuters) - Myriad Genetics Inc said a U.S. court denied its motion to temporarily stop rival Ambry Genetics Corp from selling products similar to Myriad's gene-based cancer test, the latest setback for the diagnostics company. Myriad's shares fell 12 percent before the bell on Tuesday. Myriad's problems started last June when the U.S. Supreme Court ruled that the company could not patent naturally occurring human genes, curbing the company's monopoly over a type of gene-based cancer testing. That ruling allowed other test makers, including Quest Diagnostics Inc and privately held Ambry, to develop and market the so-called BRCA tests.
Ranbaxy scrambles for ingredients to make generic Nexium
11 Mar 2014 at 5:32am
By Sumeet Chatterjee and Ben Hirschler MUMBAI/LONDON (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd is in talks with at least two companies on sourcing ingredients for a generic version of AstraZeneca Plc's heartburn drug Nexium, a source said, to ensure the pills can be sold in the United States. Washington in January prohibited Ranbaxy, India's top drugmaker by revenue, from selling drugs in the United States using ingredients from one of its plants in northern India due to poor manufacturing practices. This effectively barred it from selling drugs made in its India plants in the United States and has forced Ranbaxy to look elsewhere for supplies.
Family Petitions For Unapproved Drug To Save Son
11 Mar 2014 at 5:17am
Cancer survivor, 7, needs help fighting virus.
Florida election a bellwether for fall U.S. mid-term race
11 Mar 2014 at 4:35am
By Barbara Liston ORLANDO, Florida (Reuters) - Voters on Florida's Gulf Coast head to the polls Tuesday to fill a vacant U.S. Congressional seat in a special election watched by both major parties for what it portends for November when all 435 congressional seats will be up for grabs. Turnout is key," Susan MacManus, a longtime political analyst and professor at the University of South Florida in Tampa, told Reuters less than 24 hours before polls opened. Florida's is a big swing state, with 27 seats in the House of Representatives, tied with New York state for the third largest delegation in the nation, and behind only California and Texas. Democrats hold the advantage in the more liberal south of the state and Republicans prevail in the conservative north, while central Florida is more evenly split.
U.N. anti-drugs chief praises Iran fight despite executions
11 Mar 2014 at 4:25am
The U.N. anti-drugs chief has praised Iran's fight against narcotics trafficking despite what human rights groups describe as a surge in executions in the country, many of people convicted of drug-related offences. Yury Fedotov, executive director of the U.N. Office on Drugs and Crime (UNODC), said the Vienna-based agency opposes the death penalty and he planned to raise the issue again with Iranian officials later this week. "But on the other side, Iran takes a very active role to fight against illicit drugs," he told reporters before a international meeting in Vienna on March 13-14 on global efforts to combat narcotics. In 2012, Iran seized 388 metric tons of opium, the equivalent of 72 percent of all such seizures around the world.